Suppr超能文献

单高剂量吸入性糖皮质激素与口服泼尼松治疗对哮喘急性加重的轻至中度哮喘儿童呼出气中白三烯和8-异前列腺素水平的疗效。

The efficacy of single-high dose inhaled corticosteroid versus oral prednisone treatment on exhaled leukotriene and 8-isoprostane levels in mild to moderate asthmatic children with asthma exacerbation.

作者信息

Keskin O, Uluca U, Keskin M, Gogebakan B, Kucukosmanoglu E, Ozkars M Y, Kul S, Bayram H, Coskun Y

机构信息

Department of Pediatric Allergy and Immunology, Gaziantep University School of Medicine, Gaziantep, Turkey.

Department of Pediatrics, Gaziantep University School of Medicine, Gaziantep, Turkey.

出版信息

Allergol Immunopathol (Madr). 2016 Mar-Apr;44(2):138-48. doi: 10.1016/j.aller.2015.05.006. Epub 2015 Aug 28.

Abstract

BACKGROUND

The anti-inflammatory effect of high-dose inhaled corticosteroids (ICS) in children with asthma exacerbation is unknown. We aimed to investigate the efficacy of single-high dose ICS versus oral prednisone treatment followed by a course of six day high-dose ICS or oral prednisone (P) treatment on the concentrations of Cys-LTs and 8-isoprostane levels in the exhaled breath condensate (EBC) of children with asthma exacerbation.

METHODS

Ninety-four children with moderate-severe asthma exacerbation were evaluated with asthma scores, peak expiratory flow rate (PEF), forced expiratory volume in first second (FEV1) and exhaled Cys-LT and 8-isoprostane levels before and after treatment. EBC was collected from 52 patients before and four hours after treatment with inhaled fluticasone propionate (FP) (4000 μg) or P and after six days of treatment with FP-1000 μg/day or P. Cys-LTs and 8-isoprostane concentrations were determined using a specific immunoassay kit.

RESULTS

Both single high-dose FP (n=59) and p (n=35) treatment resulted in a significant improvement in asthma score (p<0.0001), PEF (p<0.0001), and FEV1 (p<0.0001). Cys-LT concentration in the EBC decreased significantly both after the initial treatment (p=0.001), and at the end of the six-day period in the FP group (p<0.0001). 8-Isoprostane concentration was lower only after six days of treatment with FP-1000 μg/day in the FP group (p=0.023). There was a significant decrease in exhaled Cys-LTs after four hours (p=0.012) and six days of P treatment (p=0.018) in children with asthma exacerbation.

CONCLUSIONS

High-dose ICS treatment may be useful in the treatment of children with asthma exacerbation. The effects start as early as after four hours. The suppression of Cys-LTs production contributes to the early effects. Suppression of both Cys-LTs and oxidants may favourably contribute to the effects observed later.

摘要

背景

高剂量吸入性糖皮质激素(ICS)对哮喘急性发作儿童的抗炎作用尚不清楚。我们旨在研究单次高剂量ICS与口服泼尼松治疗,随后进行为期6天的高剂量ICS或口服泼尼松(P)治疗,对哮喘急性发作儿童呼出气冷凝液(EBC)中半胱氨酰白三烯(Cys-LTs)和8-异前列腺素水平的影响。

方法

对94例中重度哮喘急性发作儿童在治疗前后进行哮喘评分、呼气峰值流速(PEF)、第1秒用力呼气容积(FEV1)以及呼出Cys-LTs和8-异前列腺素水平评估。在52例患者中,于吸入丙酸氟替卡松(FP)(4000μg)或P治疗前及治疗后4小时,以及在FP 1000μg/天或P治疗6天后采集EBC。使用特定免疫分析试剂盒测定Cys-LTs和8-异前列腺素浓度。

结果

单次高剂量FP(n = 59)和P(n = 35)治疗均使哮喘评分(p < 0.0001)、PEF(p < 0.0001)和FEV1(p < 0.0001)有显著改善。初始治疗后(p = 0.001)以及FP组6天疗程结束时(p < 0.0001),EBC中Cys-LT浓度均显著下降。仅在FP组中,FP 1000μg/天治疗6天后8-异前列腺素浓度降低(p = 0.023)。哮喘急性发作儿童在P治疗4小时(p = 0.012)和6天(p = 0.018)后呼出Cys-LTs显著下降。

结论

高剂量ICS治疗可能对哮喘急性发作儿童有效。其效果早在4小时后就开始显现。Cys-LTs生成的抑制促成了早期效果。Cys-LTs和氧化剂的抑制可能对后期观察到的效果有积极作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验